Clinical Affairs Research Collaboration Program

About Royal Biologics

Royal Biologics is a privately held, commercial-stage company operating in the high-growth orthobiologics and advanced wound care markets. It commercializes a portfolio of biologic products, primarily focusing on autologous and live cellular therapies for surgical and wound healing applications. The company demonstrates a commitment to evidence-based medicine through its external research collaboration program, supporting investigator-led studies to generate clinical data. Positioned as a rapidly expanding force, Royal Biologics aims to set benchmarks for quality and patient outcomes through continuous product development and innovation.

Therapeutic Areas